Xiaoying Fu Selected Research

Apolipoprotein A-II (Apolipoprotein A2)

8/2011	ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis.
6/2010	Mouse model to study human A beta2M amyloidosis: generation of a transgenic mouse with excessive expression of human beta2-microglobulin.
5/2010	Mouse senile amyloid fibrils deposited in skeletal muscle exhibit amyloidosis-enhancing activity.
7/2007	Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils.
7/2007	Amyloidosis in transgenic mice expressing murine amyloidogenic apolipoprotein A-II (Apoa2c).
3/2006	Transmission of amyloidosis in offspring of mice with AApoAII amyloidosis.
5/2004	Tissue distribution, biochemical properties, and transmission of mouse type A AApoAII amyloid fibrils.
11/2003	Amyloidosis modifier genes in the less amyloidogenic a/j mouse strain.
4/2003	Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence- accelerated mouse.
9/2002	Induction of protein conformational change in mouse senile amyloidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoying Fu Research Topics

Disease

19	Neoplasms (Cancer) 10/2022 - 01/2012
13	Amyloidosis 08/2011 - 09/2002
5	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2012
5	Amyloid Plaque 05/2010 - 09/2002
4	Infections 01/2016 - 05/2012
4	Carcinogenesis 11/2014 - 06/2012
4	Pleural Tuberculosis 09/2011 - 01/2011
3	Inflammation (Inflammations) 11/2021 - 07/2008
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 05/2012
3	Tuberculosis (Tuberculoses) 10/2015 - 01/2011
3	Prostatic Neoplasms (Prostate Cancer) 07/2015 - 05/2014
3	Colorectal Neoplasms (Colorectal Cancer) 03/2012 - 01/2012
3	Adenocarcinoma 01/2012 - 07/2006
2	COVID-19 09/2021 - 01/2021
2	Osteoporosis 02/2019 - 02/2016
2	Lymphatic Metastasis 06/2016 - 05/2012
2	Hyperplasia 09/2015 - 01/2013
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2022
1	Carcinoma (Carcinomatosis) 10/2022
1	Leukemia 01/2022
1	Pancreatitis 11/2021
1	Communicable Diseases (Infectious Diseases) 09/2021
1	Hemorrhage 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Bone Marrow Failure Disorders 01/2021
1	Malaria 01/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2021
1	Hemoglobinopathies 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020
1	Diabetic Cardiomyopathies 03/2020
1	Callosities 07/2019
1	Type 2 Diabetes Mellitus (MODY) 09/2016

Drug/Important Bio-Agent (IBA)

15	Amyloid (Amyloid Fibrils)IBA 06/2015 - 09/2002
10	Apolipoprotein A-II (Apolipoprotein A2)IBA 08/2011 - 09/2002
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
6	CytokinesIBA 11/2021 - 07/2009
5	Biomarkers (Surrogate Marker)IBA 03/2020 - 05/2012
4	Estrogen ReceptorsIBA 01/2021 - 01/2012
4	Amyloidogenic ProteinsIBA 05/2010 - 09/2002
3	Conditioned Culture MediaIBA 10/2022 - 12/2020
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 03/2012
3	Phenobarbital (Luminal)FDA Link 11/2014 - 03/2012
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2012
2	Messenger RNA (mRNA)IBA 06/2016 - 05/2012
2	CD40 Ligand (CD40L)IBA 10/2015 - 01/2011
2	Interleukin-2 (IL2)IBA 10/2015 - 08/2011
2	Interleukin-17 (Interleukin 17)IBA 10/2015 - 09/2013
2	TensinsIBA 07/2015 - 11/2014
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2015 - 11/2014
2	Cadherins (E-Cadherin)IBA 05/2014 - 05/2012
2	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 05/2012
2	Estrogens (Estrogen)FDA Link 03/2012 - 01/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012 - 01/2012
2	Peptides (Polypeptides)IBA 08/2011 - 01/2011
2	tributyl phosphate (TBP)IBA 01/2011 - 01/2011
2	NF-kappa B (NF-kB)IBA 07/2008 - 06/2007
2	mouse amyloidogenic apolipoprotein A-IIIBA 07/2007 - 05/2004
2	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2007 - 07/2006
2	AcidsIBA 06/2007 - 07/2006
1	Sweetening Agents (Sweeteners)IBA 11/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	olaparibIBA 01/2022
1	CeruletideIBA 11/2021
1	TrypsinogenIBA 11/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2021
1	HLA-DRB1*04 antigenIBA 09/2021
1	HLA-B Antigens (HLA-B)IBA 09/2021
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2021
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2021
1	Keratin-8 (Keratin 8)IBA 01/2021
1	DNA Restriction Enzymes (Restriction Endonuclease)IBA 01/2021
1	NucleoproteinsIBA 01/2021
1	AntibodiesIBA 12/2020
1	G-Protein-Coupled Receptor Kinase 2IBA 03/2020
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 01/2020
1	CarcinogensIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2020
1	Circular RNAIBA 01/2020
1	SulfitesIBA 07/2019
1	ChromatinIBA 02/2019
1	Glucagon (Glukagon)FDA Link 09/2016
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 09/2016
1	Acarbose FDA LinkGeneric 09/2016
1	IncretinsIBA 09/2016
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2016
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2016
1	Coloring Agents (Dyes)IBA 06/2016
1	Interleukin-22 (IL-22)IBA 01/2016
1	Immunoglobulin A (IgA)IBA 10/2015
1	AntigensIBA 10/2015
1	interleukin-21 (interleukin 21)IBA 10/2015
1	Immunoglobulins (Immunoglobulin)IBA 10/2015

Therapy/Procedure

4	Therapeutics 01/2021 - 05/2006
2	Transplantation 01/2022 - 01/2021
1	Traditional Medicine (Folk Remedies) 11/2022
1	Transcatheter Aortic Valve Replacement 01/2021
1	Patient Readmission 01/2021